Altered Expression of the Lymphocyte Activation Markers CD30 and CD27 in Patients with Pouchitis

References

• Tytgat GNJ. Pouchitis (Workshop). Int J Colorectal Dis 1989;4: 205–29.
   PubMed Web of Science ®Google Scholar
• Madden MV, Farthing MJ, Nicholls RJ. Inflammation in ileal reservoirs: ‘pouchitis’. Gut 1990;31:247–9.
   Google Scholar
• Nasmyth DG, Johnston D, Godwin PG, Dixon MF, Smith A, Williams NS. Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg 1986;73:469–73.
   PubMed Web of Science ®Google Scholar
• O’Connell PR, Rankin DR, Weiland LH, Kelly KA. Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis. Br J Surg 1986;73:909–14.
   Google Scholar
• Senju M, Hulstaert F, Lowder J, Jewell DP. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn’s disease. Gut 1991;32:779–83.
   PubMed Web of Science ®Google Scholar
• Meenan J, Spaans J, Grool TA, Pals ST, Tytgat GN, van Deventer SJ. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut 1997;40: 241–6.
   Google Scholar
• Roman LI, Manzano L, De La Hera A, Abreu L, Rossi I, Alvarez-Mon M. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn’s disease. Gastroenterology 1996;110:1008–19.
   Google Scholar
• Yacyshyn BR, Meddings JB. CD45RO expression on circulating CD19+ B cells in Crohn’s disease correlates with intestinal permeability. Gastroenterology 1995;108:132–7.
   PubMed Web of Science ®Google Scholar
• Radford-Smith G. Ulcerative colitis: an immunological disease? Baillieres Clin Gastroenterol 1997;11:35–52.
   PubMed Web of Science ®Google Scholar
• Pallone F, Monteleone G. Regulatory cytokines in inflammatory bowel disease. Aliment Pharmacol Ther 1996;10 Suppl 2:75–9.
   PubMed Web of Science ®Google Scholar
• Hintzen RQ, Lens SM, Lammers K, Kuiper H, Beckmann MP, van Lier RA. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995; 154:2612–23.
   Google Scholar
• Hintzen RQ, de Jong R, Lens SM, van Lier RA. CD27: marker and mediator of T-cell activation? Immunol Today 1994;15: 307–11.
   PubMedGoogle Scholar
• Sunder-Plassmann R, Majdic O, Knapp W, Holter W. High IL-4 production is a stable phenotype of CD8negCD45RAnegCD27-neg T cells. Cell Immunol 1995;160: 309–13.
   Google Scholar
• Tak PP, Hintzen RQ, Teunissen JJ, Smeets TJ, Daha MR, van Lier RA, et al. Expression of the activation antigen CD27 in rheumatoid arthritis. Clin Immunol Immunopathol 1996;80: 129–38.
   Google Scholar
• Yazdanbakhsh M, Sartono E, Kruize YC, Kurniawan A, van der Pouw-Kraan T, van der Meide PH, et al. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol 1993;23: 3312–7.
   Google Scholar
• Hol BE, Hintzen RQ, Van Lier RA, Alberts C, Out TA, Jansen HM. Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis. Am Rev Respir Dis 1993;148: 643–9.
   PubMed Web of Science ®Google Scholar
• Hintzen RQ, Fiszer U, Fredrikson S, Rep M, Polman CH, van Lier RA, et al. Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals. J Neuroimmunol 1995;56: 99–105.
   Google Scholar
• Meenan J, Spaans J, Grool TA, Lammers K, Pals S, Tytgat GN, et al. Variation in gut-homing CD27—negative lymphocytes in inflammatory colon disease. Scand J Immunol 1998;48:318–23.
   PubMed Web of Science ®Google Scholar
• Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin’s disease and a subset of normal lymphoid cells. Nature 1982;299:65–7.
   PubMed Web of Science ®Google Scholar
• Josimovic-Alasevic O, Durkop H, Schwarting R, Backe E, Stein H, Diamantstein T. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. Partial characterisation of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur J Immunol 1989;19: 157–62.
   Google Scholar
• Del Prete G, De Carli M, D’Elios MM, Daniel KC, Almerigogna F, Alderson M, et al. CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 1995;182: 1655–61.
   Google Scholar
• Del Prete G, De Carli M, Almerigogna F, Daniel CK, D’Elios MM, Zancuoghi G, et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995;9: 81–6.
   Google Scholar
• Nakamura T, Lee RK, Nam SY, Al-Ramadi BK, Koni PA, Bottomly K, et al. Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J Immunol 1997;158: 2090–8.
   Google Scholar
• Alzona M, Jack HM, Fisher RI, Ellis TM. IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells. J Immunol 1995;154:9–16.
   PubMed Web of Science ®Google Scholar
• Hamann D, Hilkens CM, Grogan JL, Lens SM, Kapsenberg ML, Yazdanbakhsh M, et al. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996; 156:1387–91.
   PubMed Web of Science ®Google Scholar
• Esnault S, Benbernou N, Lavaud F, Guenounou M. Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE serum levels. Clin Exp Immunol 1996;106:67–72.
   PubMed Web of Science ®Google Scholar
• Wang G, Hansen H, Tatsis E, Csernok E, Lemke H, Gross W. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener’ s garanulomatosis. Am J Med 1997;102:517–23.
   PubMed Web of Science ®Google Scholar
• Giacomelli R, Cipriani P, Lattanzio R, Di Franco M, Locanto M, Parzanese I, et al. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease. Clin Exp Immunol 1997;108: 42–6.
   Google Scholar
• Pizzolo G, Vinante F, Morosato L, Nadali G, Chilosi M, Gandini G, et al. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994;8:741–5.
   PubMed Web of Science ®Google Scholar
• Giacomelli R, Passacantando A, Parzanese I, Vernia P, Klidara N, Cucinelli F, et al. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn’s disease (CD). Clin Exp Immunol 1998;111:532–5.
   PubMed Web of Science ®Google Scholar
• Elewaut D, De Keyser F, Cuvelier A, Lazarvits AI, Mielants H, Verbruggen G, et al. Distinctive activated cellular subsets in colon from patients with Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 1998;33:743–8.
   PubMed Web of Science ®Google Scholar
• Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986;1:167–74.
   Google Scholar
• Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994;69:409–15.
   Google Scholar
• Choy MY, Walker-Smith JA, Williams CB, MacDonald TT. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn’s disease and ulcerative colitis. Gut 1990;31:1365–70.
   PubMed Web of Science ®Google Scholar
• Sasakawa T, Takizawa H, Bannai H, Narisawa R, Asakura H. Activated CD4+ and CD8+ cells in the colonic mucosa of ulcerative colitis patients: their relationship to HLA-DR antigen expression on the colonic epithelium and serum soluble CD25 levels. Digestion 1995;56: 516–22.
   Google Scholar
• Hintzen RQ, de Jong R, Lens SM, Brouwer M, Baars P, van Lier RA. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993;151:2426–35.
   PubMed Web of Science ®Google Scholar
• Mavilia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, Emmi L, et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997;151: 1751–8.
   PubMed Web of Science ®Google Scholar
• Agrawal B, Reddish M, Longenecker BM. CD30 expression on human CD8+ T cells isolated from peripheral blood lymphocytes of normal donors. J Immunol 1996;157: 3229–34.
   Google Scholar
• Annunziato F, Manetti R, Cosmi L, Galli G, Heusser CH, Romagnani S, et al. Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur J Immunol 1997;27:2239–44.
   PubMed Web of Science ®Google Scholar
• Nadali G, Vinante F, Ambrosetti A, Todeschini G, Veneri D, Zanotti R, et al. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin’ s disease and correlate with clinical features and prognosis. J Clin Oncol 1994;12:793–7.
   PubMed Web of Science ®Google Scholar
• Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn’s disease. Am J Pathol 1997;150:823–32.
   PubMed Web of Science ®Google Scholar
• D’Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997;27: 1751–5.
   Google Scholar
• Stallmach A, Schafer F, Hoffmann S, Weber S, Muller-Molaian I, Schneider T, et al. Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis. Gut 1998;43: 499–505.
   Google Scholar